Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

106
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
106
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

3.8K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.8K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

325
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
325
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

54
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
54
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

766
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
766
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

50
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
50

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the bladder: incontinence-specific, physical, and psychological contributors to sexual function in women with urinary incontinence.

The journal of sexual medicine·2026
Same author

Associations of urinary incontinence, absorbent product use, and confidence gained from absorbent product use with perceived ageism in later adulthood.

The Gerontologist·2026
Same author

Lower Urinary Tract Symptoms and Cognitive Impairment Among Participants in the REGARDS Cohort Study.

Journal of the American Geriatrics Society·2026
Same author

Effects of Hatha Yoga vs Physical Conditioning on Sleep in Women With Urinary Incontinence: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2025
Same author

Sexual Function in a Randomized Trial of Pelvic Yoga for Urinary Incontinence.

Urogynecology (Philadelphia, Pa.)·2025
Same author

Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future Research.

Toxins·2025

Related Experiment Video

Updated: Sep 24, 2025

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.4K

Barriers and facilitators to overactive bladder therapy adherence.

Ekene A Enemchukwu1, Leslee L Subak2, Alayne Markland3

  • 1Department of Urology, Stanford University School of Medicine, Palo Alto, California, USA.

Neurourology and Urodynamics
|May 5, 2022
PubMed
Summary
This summary is machine-generated.

Improving overactive bladder (OAB) therapy adherence requires addressing modifiable patient barriers. Patient-centered care, including treatment navigators, can enhance adherence and outcomes, reducing healthcare costs.

Keywords:
behavioral therapyoveractive bladderpatient-centered carepharmacotherapytherapy adherencethird-line therapyurinary incontinence

More Related Videos

Real-Time Void Spot Assay
06:39

Real-Time Void Spot Assay

Published on: February 10, 2023

2.2K
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.1K

Related Experiment Videos

Last Updated: Sep 24, 2025

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.4K
Real-Time Void Spot Assay
06:39

Real-Time Void Spot Assay

Published on: February 10, 2023

2.2K
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.1K

Area of Science:

  • Urology
  • Patient Adherence Research
  • Healthcare Management

Background:

  • Overactive bladder (OAB) therapy adherence is crucial for managing symptoms and improving quality of life.
  • Low adherence rates to behavioral therapies (32% at 1 year) and oral medications (15%-40% at 1 year) significantly impact treatment effectiveness.
  • A substantial number of OAB patients do not progress to advanced therapies due to adherence issues.

Purpose of the Study:

  • To identify and analyze barriers and facilitators influencing overactive bladder (OAB) therapy initiation and adherence.
  • To explore the impact of patient-centered care strategies on OAB treatment adherence.
  • To provide insights for improving patient outcomes and reducing healthcare expenditures related to OAB.

Main Methods:

  • A comprehensive literature search was conducted using PubMed and Embase databases.
  • The search focused on identifying factors that hinder or support adherence to OAB therapies.
  • Analysis included both fixed and modifiable barriers to treatment.

Main Results:

  • Adherence to OAB therapies is linked to improved urinary symptoms, enhanced quality of life, and reduced healthcare costs.
  • Common barriers include inadequate efficacy, tolerability issues, cost, lack of knowledge, and poor provider communication.
  • Patient-centered care, particularly through treatment navigators, shows promise in improving adherence and facilitating progression to advanced therapies.

Conclusions:

  • Numerous modifiable barriers impede OAB therapy adherence, necessitating a patient-centered approach.
  • Tailoring therapy to individual patient goals and expectations is key to optimizing adherence and outcomes.
  • Further research into scalable, cost-effective solutions is essential for widespread implementation.